NCT04922229

Brief Summary

This project addresses a central question within the practice of dentistry: Is a pulpotomy procedure effective in the treatment of a tooth with symptomatic irreversible pulpitis and normal periapex? In addition, the project seeks to identify clinical and molecular biomarkers that are predictive of the success of pulpotomy.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
138

participants targeted

Target at P50-P75 for not_applicable

Timeline
56mo left

Started Jun 2027

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 10, 2021

Completed
6 years until next milestone

Study Start

First participant enrolled

June 1, 2027

Expected
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2030

1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2031

Last Updated

February 17, 2026

Status Verified

February 1, 2026

Enrollment Period

3.1 years

First QC Date

June 4, 2021

Last Update Submit

February 12, 2026

Conditions

Keywords

PulpotomyVital Pulp Therapy

Outcome Measures

Primary Outcomes (1)

  • Percentage of patients with a successful outcome of pulpotomy versus RCT

    A composite of clinical and radiographic findings and incidence of follow up procedures

    From baseline through 2 years

Secondary Outcomes (2)

  • Determine prognostic validity of preoperative hyperalgesia in determining the outcome of pulpotomy

    From baseline to two years

  • Determine prognostic validity of a set of pulpal inflammatory proteins in determining the outcome of pulpotomy

    From baseline to 2 years

Study Arms (2)

Root canal treatment (RCT)

ACTIVE COMPARATOR

For cases with this diagnosis RCT is the standard of care and will be done according to clinically approved protocols

Procedure: RCT

Pulpotomy

EXPERIMENTAL

Pulpotomy with tricalcium silicates has shown high clinical success in these cases. However, it is not known how this success compares to RCT under similar conditions and with an intent-to-treat study design, which will be employed here.

Procedure: Pulpotomy

Interventions

RCTPROCEDURE

This is the standard of care for this diagnosis

Also known as: Endodontic therapy
Root canal treatment (RCT)
PulpotomyPROCEDURE

For cases with normal apical tissues, pulpotomy using tricalcium silicates has been shown to have high clinical success. Either partial or complete pulpotomy will be performed depending on the size of pulp exposure.

Also known as: Therapeutic pulpotomy
Pulpotomy

Eligibility Criteria

Age12 Years - 99 Years
Sexall(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Maxillary or mandibular first or second mature permanent molars with carious lesions or restorations (excluding crowns), with signs and symptoms of symptomatic irreversible pulpitis (defined as spontaneous pulpal pain and cold hyperalgesia \>30 seconds), and normal apical tissues.
  • Tooth is responsive to cold and electrical pulp testing.
  • Patients aged ≥12 years for first molars and ≥16 years for second molars.

You may not qualify if:

  • Evidence of Pulp Necrosis or Apical Periodontitis, preoperatively or upon inspection of an exposure site
  • Teeth that are badly broken down and/or are not restorable.
  • Teeth with mechanical allodynia assessed by registering bite force that is at least 50N lower than the contralateral side.
  • Teeth with radiographic evidence of internal, or external cervical, inflammatory or replacement root resorption, or with complete pulp canal obliteration.
  • Radiographic evidence of PDL space wider than three times normal width
  • Clinical evidence of swelling or sinus tract
  • Periodontal pocket probing depth ≥5 mm in any site around the tooth.
  • Clinical evidence of cracks connecting mesial and distal surfaces and/or extending in pulp chamber or associated with periodontal pockets ≥ 5 mm.
  • History of taking centrally acting drugs (e.g., tricyclic antidepressants), which interfere with the release of pain mediators and/or modify pain experience, within the previous 6 months.
  • Use of medications that affect the host response such as methotrexate, corticosteroids or cyclosporin.
  • Patients on immunosuppressive agents, chronic corticosteroid use, autoimmune disease, or other immunocompromising diseases or medications.
  • Patients who require IV sedation or general anesthesia for their dental treatment.
  • Teeth with full coverage crowns.
  • Teeth undergoing active orthodontic movement.
  • Teeth that require elective RCTx to place a post for restorative purposes.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Dentistry, University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States

Location

MeSH Terms

Interventions

Dental Implantation, Endosseous, EndodonticPulpotomy

Intervention Hierarchy (Ancestors)

Dental Implantation, EndosseousDental ImplantationOral Surgical Procedures, PreprostheticOral Surgical ProceduresSurgical Procedures, OperativeProsthesis ImplantationEndodonticsDentistryProsthodontics

Study Officials

  • Ashraf Fouad, DDS

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sheila Turner, DDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Chair

Study Record Dates

First Submitted

June 4, 2021

First Posted

June 10, 2021

Study Start (Estimated)

June 1, 2027

Primary Completion (Estimated)

June 30, 2030

Study Completion (Estimated)

December 31, 2031

Last Updated

February 17, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

To be determined

Locations